Paul C. Levy

657 total citations
21 papers, 513 citations indexed

About

Paul C. Levy is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Paul C. Levy has authored 21 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Paul C. Levy's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Air Quality and Health Impacts (3 papers). Paul C. Levy is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Air Quality and Health Impacts (3 papers). Paul C. Levy collaborates with scholars based in United States. Paul C. Levy's co-authors include Albert F. LoBuglio, George M. Shaw, Suzann K. Campbell, Mark J. Utell, R. John Looney, Daniel H. Ryan, Mark W. Frampton, Paul E. Morrow, Norbert J. Roberts and Donna M. Speers and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and CHEST Journal.

In The Last Decade

Paul C. Levy

18 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul C. Levy United States 13 166 99 82 63 61 21 513
C Sgro France 9 63 0.4× 94 0.9× 59 0.7× 77 1.2× 4 0.1× 53 422
J. S. S. Gear South Africa 10 204 1.2× 32 0.3× 23 0.3× 28 0.4× 7 0.1× 24 652
Michael Thick United Kingdom 15 124 0.7× 32 0.3× 23 0.3× 48 0.8× 5 0.1× 31 842
Ines Schaefer Germany 9 370 2.2× 37 0.4× 44 0.5× 60 1.0× 4 0.1× 16 933
Nílzio Antônio da Silva Brazil 17 126 0.8× 54 0.5× 20 0.2× 17 0.3× 8 0.1× 53 700
Shuyuan Chu China 12 133 0.8× 75 0.8× 14 0.2× 127 2.0× 8 0.1× 33 459
Duncan Cole United Kingdom 12 110 0.7× 63 0.6× 17 0.2× 87 1.4× 3 0.0× 35 498
Sandrine Kerbrat France 9 75 0.5× 48 0.5× 28 0.3× 62 1.0× 5 0.1× 27 349
Thomas Bastholm Olesen Denmark 13 155 0.9× 122 1.2× 22 0.3× 16 0.3× 4 0.1× 38 610

Countries citing papers authored by Paul C. Levy

Since Specialization
Citations

This map shows the geographic impact of Paul C. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul C. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul C. Levy more than expected).

Fields of papers citing papers by Paul C. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul C. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul C. Levy. The network helps show where Paul C. Levy may publish in the future.

Co-authorship network of co-authors of Paul C. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Paul C. Levy. A scholar is included among the top collaborators of Paul C. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul C. Levy. Paul C. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Connolly, Margaret, Kelly Thevenet-Morrison, Paul C. Levy, et al.. (2024). Tuberculosis screening for patients on biologic Medications: A Single-Center experience and Society guideline Review, Monroe County, New York, 2018–2021. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 36. 100460–100460.
3.
Poe, Robert H. & Paul C. Levy. (2023). Diagnosis and treatment of sarcoidosis. Frontiers research topics. 19(5). 209–13.
4.
Nofziger, Anne C., et al.. (2020). Incorporating Medical Student Documentation Into the Billable Encounter. CHEST Journal. 158(2). 698–704. 1 indexed citations
5.
Levy, Paul C., et al.. (2014). Copy, Paste, and Cloned Notes in Electronic Health Records. CHEST Journal. 145(3). 632–638. 93 indexed citations
6.
Campbell, Suzann K., et al.. (2006). Population-Based Age Standards for Interpreting Results on the Test of Motor Infant Performance. Pediatric Physical Therapy. 18(2). 119–125. 48 indexed citations
7.
Frampton, Mark W., Paul E. Morrow, C. Cox, et al.. (1995). Sulfuric Acid Aerosol Followed by Ozone Exposure in Healthy and Asthmatic Subjects. Environmental Research. 69(1). 1–14. 24 indexed citations
8.
Levy, Paul C., Mark J. Utell, Joshua Z. Sickel, & Michael J. Apostolakos. (1995). The acute respiratory distress syndrome: current trends in pathogenesis and management.. PubMed. 21(8). 438–44. 8 indexed citations
9.
Apostolakos, Michael J., Paul C. Levy, & Peter J. Papadakos. (1995). New Modes of Mechanical Ventilation. Clinical Pulmonary Medicine. 2(2). 121–128. 3 indexed citations
10.
Poe, Robert H., et al.. (1994). Use of Fiberoptic Bronchoscopy in the Diagnosis of Bronchogenic Carcinoma: A Study in Patients With Idiopathic Pleural Effusions. CHEST Journal. 105(6). 1663–1667. 14 indexed citations
11.
Frampton, Mark W., Daniel H. Ryan, Paul C. Levy, et al.. (1994). Expression of Membrane Antigens on Human Alveolar Macrophages after Exposure to Nitrogen Dioxide. Inhalation Toxicology. 6(6). 633–646. 12 indexed citations
12.
Utell, Mark J., Mark W. Frampton, Paul E. Morrow, et al.. (1994). Oxidant and acid aerosol exposure in healthy subjects and subjects with asthma. Part II: Effects of sequential sulfuric acid and ozone exposures on the pulmonary function of healthy subjects and subjects with asthma.. PubMed. 37–93, discussion 95. 6 indexed citations
13.
Levy, Paul C., Mark J. Utell, Howard B. Fleit, et al.. (1991). Characterization of Human Alveolar Macrophage Fcγ Receptor III: A Transmembrane Glycoprotein that is Shed under In Vitro Culture Conditions. American Journal of Respiratory Cell and Molecular Biology. 5(4). 307–314. 19 indexed citations
14.
Levy, Paul C., R. John Looney, Li Shen, et al.. (1990). Human alveolar macrophage FcR-mediated cytotoxicity. Heteroantibody- versus conventional antibody-mediated target cell lysis.. The Journal of Immunology. 144(10). 3693–3700. 9 indexed citations
15.
Levy, Paul C., George M. Shaw, & Albert F. LoBuglio. (1979). Human monocyte, lymphocyte, and granulocyte antibody-dependent cell-mediated cytotoxicity toward tumor cells. I. General characteristics of cytolysis.. PubMed. 123(2). 594–9. 62 indexed citations
16.
Shaw, George M., Paul C. Levy, & Albert F. LoBuglio. (1979). Re-examination of the EA rosette assay (Ripley) for Fc receptor leucocytes.. PubMed. 36(3). 496–501. 15 indexed citations
17.
Levy, Paul C., George M. Shaw, & Albert F. LoBuglio. (1979). Human Monocyte, Lymphocyte, and Granulocyte Antibody-Dependent Cell-Mediated Cytotoxicity Toward Tumor Cells. The Journal of Immunology. 123(2). 594–599. 33 indexed citations
18.
Shaw, George M., Paul C. Levy, & Albert F. LoBuglio. (1978). Human lymphocyte, monocyte, and neutrophil antibody-dependent cell-mediated cytotoxicity toward human erythrocytes. Cellular Immunology. 41(1). 122–133. 33 indexed citations
19.
Shaw, George M., Paul C. Levy, & Albert F. LoBuglio. (1978). Human Monocyte Cytotoxicity to Tumor Cells. The Journal of Immunology. 121(2). 573–578. 31 indexed citations
20.
Shaw, George M., Paul C. Levy, & Albert F. LoBuglio. (1978). Human Monocyte Antibody-Dependent Cell-Mediated Cytotoxicity to Tumor Cells. Journal of Clinical Investigation. 62(6). 1172–1180. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026